Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma. Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2, known as CRTh2) antagonist and currently in development for the treatment o
Molecular Weight:
426.41
CAS Number:
[872365-14-5]
* VAT and and shipping costs not included. Errors and price changes excepted